{ "cik": 105770, "cik_padded": "0000105770", "entityName": "WEST PHARMACEUTICAL SERVICES INC", "fiscal_years": [ { "accn": "0000105770-26-000010", "filed": "2026-02-17", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 134000000.0, "capex": 285900000.0, "cash": 791300000.0, "cost_of_revenue": 1970100000.0, "dividends_paid": 61200000.0, "eps_diluted": 6.79, "free_cash_flow": 468900000.0, "gross_profit": 1104000000.0, "net_income": 493700000.0, "operating_cash_flow": 754800000.0, "operating_income": 584900000.0, "revenue": 3074100000.0, "stockholders_equity": 3176000000.0, "total_assets": 4270000000.0, "total_liabilities": 1094000000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.35912950131745874, "leverage": 0.34445843828715367, "net_margin": 0.16059985036270782, "operating_margin": 0.1902670700367587, "payout_ratio": 0.12396192019445007, "revenue_growth_yoy": 0.06252592285358773, "roa_avg2y": 0.1247756969191498, "roa_period_end": 0.11562060889929743, "roe_avg2y": 0.1685471894576925, "roe_period_end": 0.15544710327455918 } }, { "accn": "0000105770-26-000010", "filed": "2026-02-17", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 560900000.0, "capex": 377000000.0, "cash": 484600000.0, "cost_of_revenue": 1894700000.0, "dividends_paid": 59100000.0, "eps_diluted": 6.69, "free_cash_flow": 276400000.0, "gross_profit": 998500000.0, "net_income": 492700000.0, "operating_cash_flow": 653400000.0, "operating_income": 569900000.0, "revenue": 2893200000.0, "stockholders_equity": 2682300000.0, "total_assets": 3643400000.0, "total_liabilities": 961100000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.34511959076455134, "leverage": 0.3583118965067293, "net_margin": 0.17029586616894787, "operating_margin": 0.19697912346191068, "payout_ratio": 0.11995128881672418, "revenue_growth_yoy": -0.019187741541799443, "roa_avg2y": 0.13186313211738415, "roa_period_end": 0.13523082834714828, "roe_avg2y": 0.1771250876278468, "roe_period_end": 0.18368564291839093 } }, { "accn": "0000105770-26-000010", "filed": "2026-02-17", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 438300000.0, "capex": 362000000.0, "cash": 853900000.0, "cost_of_revenue": 1820600000.0, "dividends_paid": 57000000.0, "eps_diluted": 7.88, "free_cash_flow": 414500000.0, "gross_profit": 1129200000.0, "net_income": 593400000.0, "operating_cash_flow": 776500000.0, "operating_income": 676000000.0, "revenue": 2949800000.0, "stockholders_equity": 2881000000.0, "total_assets": 3829500000.0, "total_liabilities": 948500000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.3828056139399281, "leverage": 0.3292259632072197, "net_margin": 0.2011661807580175, "operating_margin": 0.22916807919180962, "payout_ratio": 0.09605662285136501, "revenue_growth_yoy": 0.021788077176209775, "roa_avg2y": 0.15938116917126627, "roa_period_end": 0.15495495495495495, "roe_avg2y": 0.21322697137929175, "roe_period_end": 0.20597014925373133 } }, { "accn": "0000105770-26-000010", "filed": "2026-02-17", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 202800000.0, "capex": 284600000.0, "cash": 894300000.0, "cost_of_revenue": 1750700000.0, "dividends_paid": 54100000.0, "eps_diluted": 7.73, "free_cash_flow": 439400000.0, "gross_profit": 1136200000.0, "net_income": 585900000.0, "operating_cash_flow": 724000000.0, "operating_income": 734000000.0, "revenue": 2886900000.0, "stockholders_equity": 2684900000.0, "total_assets": 3616800000.0, "total_liabilities": 931900000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.39357095846756035, "leverage": 0.3470892770680472, "net_margin": 0.20295126260002078, "operating_margin": 0.2542519657764384, "payout_ratio": 0.09233657620754394, "revenue_growth_yoy": 0.019529594575505016, "roa_avg2y": 0.16907627045277465, "roa_period_end": 0.16199402786994027, "roe_avg2y": 0.23341234587574447, "roe_period_end": 0.21822041789265895 } }, { "accn": "0000105770-25-000013", "filed": "2025-02-18", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 137100000.0, "capex": 253400000.0, "cash": 762600000.0, "cost_of_revenue": 1655800000.0, "dividends_paid": 51100000.0, "eps_diluted": 8.67, "free_cash_flow": 330600000.0, "gross_profit": 1175800000.0, "net_income": 661800000.0, "operating_cash_flow": 584000000.0, "operating_income": 752300000.0, "revenue": 2831600000.0, "stockholders_equity": 2335400000.0, "total_assets": 3313800000.0, "total_liabilities": 978400000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.41524226585675944, "leverage": 0.418943221717907, "net_margin": 0.23371945189998589, "operating_margin": 0.2656801808164995, "payout_ratio": 0.07721365971592627, "revenue_growth_yoy": 0.3189249615724999, "roa_avg2y": 0.21671360272447443, "roa_period_end": 0.19971030237189932, "roe_avg2y": 0.31590252750662307, "roe_period_end": 0.2833775798578402 } }, { "accn": "0001628280-22-003342", "filed": "2024-02-20", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 115500000.0, "capex": 174400000.0, "cash": 615500000.0, "cost_of_revenue": 1379100000.0, "dividends_paid": 48100000.0, "eps_diluted": 4.57, "free_cash_flow": 298100000.0, "gross_profit": 767800000.0, "net_income": 346200000.0, "operating_cash_flow": 472500000.0, "operating_income": 406900000.0, "revenue": 2146900000.0, "stockholders_equity": 1854500000.0, "total_assets": 2793800000.0, "total_liabilities": 939300000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.3576319344170665, "leverage": 0.5064977082771637, "net_margin": 0.16125576412501746, "operating_margin": 0.18952908845311847, "payout_ratio": 0.1389370306181398, "revenue_growth_yoy": 0.16685689439643459, "roa_avg2y": 0.13483408630627824, "roa_period_end": 0.12391724532894266, "roe_avg2y": 0.2020013420077603, "roe_period_end": 0.1866810461040712 } }, { "accn": "0001628280-22-003342", "filed": "2023-02-21", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 83100000.0, "capex": 126400000.0, "cash": 439100000.0, "cost_of_revenue": 1234200000.0, "dividends_paid": 45100000.0, "eps_diluted": 3.21, "free_cash_flow": 240800000.0, "gross_profit": 605700000.0, "net_income": 241700000.0, "operating_cash_flow": 367200000.0, "operating_income": 296600000.0, "revenue": 1839900000.0, "stockholders_equity": 1573200000.0, "total_assets": 2341400000.0, "total_liabilities": 768200000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.3292026740583727, "leverage": 0.48830409356725146, "net_margin": 0.13136583509973368, "operating_margin": 0.16120441328333063, "payout_ratio": 0.18659495242035581, "revenue_growth_yoy": 0.07132875276580879, "roa_avg2y": 0.11189037798301044, "roa_period_end": 0.10322883744768087, "roe_avg2y": 0.16278834820676882, "roe_period_end": 0.15363590134757182 } }, { "accn": "0001628280-22-003342", "filed": "2022-02-22", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 70800000.0, "capex": 104700000.0, "cash": 337400000.0, "cost_of_revenue": 1172000000.0, "dividends_paid": 42100000.0, "eps_diluted": 2.74, "free_cash_flow": 183900000.0, "gross_profit": 545400000.0, "net_income": 206900000.0, "operating_cash_flow": 288600000.0, "operating_income": 240300000.0, "revenue": 1717400000.0, "stockholders_equity": 1396300000.0, "total_assets": 1978900000.0, "total_liabilities": 582600000.0 }, "period_end": "2018-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.31757307557936415, "leverage": 0.4172455775979374, "net_margin": 0.12047280773261909, "operating_margin": 0.13992081052754163, "payout_ratio": 0.20347994200096664, "roa_avg2y": 0.10771273134289507, "roa_period_end": 0.10455303451412401, "roe_avg2y": 0.15462222554368135, "roe_period_end": 0.14817732578958676 } }, { "accn": "0000105770-21-000008", "filed": "2021-02-23", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 74400000.0, "capex": 130800000.0, "cash": 235900000.0, "dividends_paid": 39100000.0, "eps_diluted": 1.99, "free_cash_flow": 132500000.0, "gross_profit": 512900000.0, "operating_cash_flow": 263300000.0, "operating_income": 225800000.0, "stockholders_equity": 1279900000.0, "total_assets": 1862800000.0, "total_liabilities": 582900000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio" }, "ratios": { "leverage": 0.4554262051722791 } }, { "accn": "0000105770-20-000015", "filed": "2020-02-24", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 52200000.0, "capex": 170200000.0, "cash": 203000000.0, "dividends_paid": 35800000.0, "eps_diluted": 1.91, "free_cash_flow": 49200000.0, "gross_profit": 501400000.0, "operating_cash_flow": 219400000.0, "operating_income": 195200000.0, "total_assets": 1716700000.0, "total_liabilities": 599200000.0 }, "period_end": "2016-12-31", "ratios": {} }, { "accn": "0000105770-11-000016", "filed": "2011-02-28", "fiscal_year": 2010, "form": "10-K", "fundamental_units": { "net_income": "USD" }, "fundamentals": { "net_income": 65300000.0 }, "period_end": "2010-12-31", "ratios": {} }, { "accn": "0000105770-11-000016", "filed": "2011-02-28", "fiscal_year": 2009, "form": "10-K", "fundamental_units": { "net_income": "USD" }, "fundamentals": { "net_income": 72600000.0 }, "period_end": "2009-12-31", "ratios": {} } ], "latest_filing": { "accn": "0000105770-26-000010", "filed": "2026-02-17", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3841", "sic_description": "Surgical & Medical Instruments & Apparatus", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000105770.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000105770.json" }, "ticker": "WST" }